Phillip Foreman

Phillip Foreman

Nessuna posizione attualmente

Health Technology
Process Industries
Health Services

Profilo

Phillip Foreman has been a Director of TheraBiogen, Inc. since August 31, 2008.
Dr. Forman was appointed as Medical Director of the New York Hyperbaric in 2001.
From July 2005 to January 18, 2007, he served as Chief Executive Officer of American Hyperbaric, Inc. Previously, Dr. Forman was a Principal at Merck & Co., Inc., Pharmacia, OrthoBiotech, Novartis/Organogenesis, Johnson & Johnson, Monsanto, Ortho-McNiel, Alpha Therapeutics, and Ortec International.
He was a Principal at Staten Island University Hospital and Associate and a Director of Residency Program for Staten Island University Hospital.
Dr. Forman has extensive experience in wound care.
He received a degree from the American Board of Podiatric Surgery and a PhD in Podiatric Medicine from the Pennsylvania College of Podiatric Medicine.

Precedenti posizioni note di Phillip Foreman

SocietàPosizioneFine
Direttore/Membro del Consiglio 07/01/2010
American Hyperbaric, Inc. Presidente 18/01/2007
Corporate Officer/Principal -
Corporate Officer/Principal -
Alpha Therapeutics Corp. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Phillip Foreman

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Phillip Foreman

Relazioni

7

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private11

Health Technology

Health Technology

Health Technology

Process Industries

Health Services

Health Technology

Process Industries

American Hyperbaric, Inc.

Health Services

Consumer Non-Durables

New York Hyperbaric

Alpha Therapeutics Corp.

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Phillip Foreman